Please use this identifier to cite or link to this item:
https://hdl.handle.net/1/2474Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Bamford, Paul | - |
| dc.contributor.author | Rogers, James | - |
| dc.date.accessioned | 2024-02-14T03:04:24Z | - |
| dc.date.available | 2024-02-14T03:04:24Z | - |
| dc.date.issued | 2019-05-14 | - |
| dc.identifier.citation | 40(19):1567 | en |
| dc.identifier.uri | https://hdl.handle.net/1/2474 | - |
| dc.description.abstract | No abstract available | en |
| dc.description.sponsorship | Cardiology | en |
| dc.subject | Cardiology | en |
| dc.subject | Drug Therapy | en |
| dc.title | Where's the bleed? A response to Piccini et al.'s: Management of major bleeding events in patients treated with rivaroxaban vs. warfarin: results from the ROCKET AF trial | en |
| dc.type | Journal Article | en |
| dc.identifier.doi | 10.1093/eurheartj/ehy739 | en |
| dc.description.pubmeduri | https://pubmed.ncbi.nlm.nih.gov/30476023 | en |
| dc.description.affiliates | Central Coast Local Health District | en |
| dc.description.affiliates | Gosford Hospital | en |
| dc.identifier.journaltitle | European Heart Journal | en |
| dc.type.content | Text | en |
| item.grantfulltext | none | - |
| item.fulltext | No Fulltext | - |
| item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
| item.openairetype | Journal Article | - |
| item.cerifentitytype | Publications | - |
| Appears in Collections: | Health Service Research | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.